PAR6 MODELING THE IMPACT OF PATIENT AND CLINICAL HETEROGENEITIES ON THE COST-EFFECTIVENESS OF SELECTIVE COX-2 INHIBITORS SUCH AS LUMIRACOXIB AND CONVENTIONAL NSAIDS IN PATIENTS WITH OSTEOARTHRITIS

✍ Scribed by J Huels; A Wright; K Kahler; M Omar; RW Dubois; CF Chiou; OV Doan

• Book ID: 119595262
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 79 KB
• Volume: 9
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)64387-2